Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?
- Resource Type
- Article
- Source
Lupus . Mar2023, Vol. 32 Issue 3, p453-455. 3p. 1 Chart.- Subject
- *
COVID-19
*COUGH
*SYSTEMIC lupus erythematosus
*CLINICAL trials
*COVID-19 pandemic
*SARS-CoV-2 Omicron variant
*SKIN diseases - Language
- ISSN
- 0961-2033